Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis | 5 | 2014 | 1087 | 0.800 |
Why?
|
Diclofenac | 1 | 2014 | 69 | 0.440 |
Why?
|
Indomethacin | 1 | 2014 | 323 | 0.430 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 4 | 2014 | 520 | 0.400 |
Why?
|
Hematocrit | 2 | 2007 | 623 | 0.300 |
Why?
|
Pleural Effusion | 1 | 2007 | 344 | 0.230 |
Why?
|
Research Support as Topic | 1 | 2006 | 696 | 0.200 |
Why?
|
Pancreas | 4 | 2010 | 1700 | 0.200 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2002 | 174 | 0.170 |
Why?
|
Fluid Therapy | 1 | 2002 | 587 | 0.150 |
Why?
|
Esophageal Neoplasms | 2 | 2005 | 1668 | 0.140 |
Why?
|
Resuscitation | 1 | 2002 | 679 | 0.140 |
Why?
|
Inpatients | 1 | 2008 | 2566 | 0.130 |
Why?
|
Secretin | 2 | 2013 | 57 | 0.130 |
Why?
|
Length of Stay | 3 | 2008 | 6498 | 0.130 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1465 | 0.120 |
Why?
|
Pancreatic Cyst | 2 | 2009 | 372 | 0.120 |
Why?
|
Administration, Rectal | 1 | 2014 | 69 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2004 | 1481 | 0.110 |
Why?
|
Pancreatic Function Tests | 1 | 2013 | 69 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2009 | 15948 | 0.100 |
Why?
|
Acute Disease | 3 | 2008 | 7243 | 0.090 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8054 | 0.090 |
Why?
|
Pancreatitis, Chronic | 1 | 2013 | 282 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 2005 | 6395 | 0.090 |
Why?
|
Body Mass Index | 1 | 2007 | 13053 | 0.080 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 100 | 0.080 |
Why?
|
Biliary Tract | 1 | 2010 | 135 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 4058 | 0.080 |
Why?
|
Carcinoembryonic Antigen | 1 | 2009 | 338 | 0.070 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2009 | 195 | 0.070 |
Why?
|
Capsule Endoscopes | 1 | 2006 | 13 | 0.070 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2006 | 44 | 0.060 |
Why?
|
Capsule Endoscopy | 1 | 2006 | 106 | 0.060 |
Why?
|
Pancreatic Pseudocyst | 1 | 2005 | 112 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2007 | 994 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2271 | 0.060 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2006 | 236 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1744 | 0.050 |
Why?
|
Placebo Effect | 1 | 2007 | 517 | 0.050 |
Why?
|
Peer Review, Research | 1 | 2006 | 344 | 0.050 |
Why?
|
Gallstones | 1 | 2006 | 285 | 0.050 |
Why?
|
Digestive System Diseases | 1 | 2004 | 152 | 0.050 |
Why?
|
Intestinal Obstruction | 1 | 2006 | 433 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2010 | 1424 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2005 | 495 | 0.050 |
Why?
|
Pancreatic Neoplasms | 2 | 2009 | 5446 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2007 | 1321 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 10399 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2005 | 985 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15454 | 0.040 |
Why?
|
Necrosis | 1 | 2002 | 1616 | 0.040 |
Why?
|
Attitude to Health | 1 | 2005 | 2025 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2014 | 65371 | 0.030 |
Why?
|
Liver Diseases | 1 | 2004 | 1305 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2007 | 1926 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3479 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2008 | 5349 | 0.030 |
Why?
|
Humans | 16 | 2014 | 768166 | 0.030 |
Why?
|
Crohn Disease | 1 | 2006 | 2295 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 8080 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7454 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 13014 | 0.020 |
Why?
|
Prognosis | 2 | 2009 | 30010 | 0.020 |
Why?
|
Common Bile Duct | 1 | 2010 | 106 | 0.020 |
Why?
|
Middle Aged | 8 | 2009 | 223492 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2013 | 81762 | 0.020 |
Why?
|
Aged | 6 | 2009 | 171504 | 0.020 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2009 | 51 | 0.020 |
Why?
|
Cystadenoma, Mucinous | 1 | 2009 | 62 | 0.020 |
Why?
|
Allelic Imbalance | 1 | 2009 | 77 | 0.020 |
Why?
|
Risk Factors | 2 | 2007 | 74944 | 0.020 |
Why?
|
Cyst Fluid | 1 | 2009 | 86 | 0.020 |
Why?
|
Bile Ducts | 1 | 2010 | 288 | 0.020 |
Why?
|
Mass Screening | 1 | 2004 | 5458 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2009 | 699 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1194 | 0.020 |
Why?
|
Female | 10 | 2013 | 397192 | 0.020 |
Why?
|
Male | 9 | 2013 | 364719 | 0.020 |
Why?
|
Adult | 5 | 2013 | 223646 | 0.020 |
Why?
|
Infant | 1 | 2008 | 36535 | 0.020 |
Why?
|
Exudates and Transudates | 1 | 2006 | 175 | 0.020 |
Why?
|
Child, Preschool | 1 | 2008 | 42669 | 0.020 |
Why?
|
Cholangitis | 1 | 2006 | 110 | 0.010 |
Why?
|
Endosonography | 1 | 2009 | 626 | 0.010 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2009 | 526 | 0.010 |
Why?
|
North Carolina | 1 | 2005 | 329 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2009 | 1135 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1596 | 0.010 |
Why?
|
ras Proteins | 1 | 2009 | 1058 | 0.010 |
Why?
|
Cholecystectomy | 1 | 2006 | 408 | 0.010 |
Why?
|
Esophagoscopy | 1 | 2005 | 398 | 0.010 |
Why?
|
Biliary Tract Diseases | 1 | 2004 | 159 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 59629 | 0.010 |
Why?
|
Child | 2 | 2008 | 80917 | 0.010 |
Why?
|
Adolescent | 2 | 2008 | 89169 | 0.010 |
Why?
|
United States | 2 | 2008 | 73039 | 0.010 |
Why?
|
Risk Management | 1 | 2005 | 558 | 0.010 |
Why?
|
Remission Induction | 1 | 2007 | 2410 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1767 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2009 | 1523 | 0.010 |
Why?
|
Logistic Models | 2 | 2005 | 13290 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2278 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2923 | 0.010 |
Why?
|
Risk-Taking | 1 | 2005 | 1023 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2873 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2846 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3533 | 0.010 |
Why?
|
Drainage | 1 | 2005 | 1183 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9384 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14729 | 0.010 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1757 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1798 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4528 | 0.010 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2004 | 957 | 0.010 |
Why?
|
Patient Participation | 1 | 2005 | 1447 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2004 | 1206 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 6983 | 0.010 |
Why?
|
Population Surveillance | 1 | 2005 | 2596 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5884 | 0.010 |
Why?
|
Stents | 1 | 2006 | 3195 | 0.010 |
Why?
|
Cause of Death | 1 | 2004 | 3721 | 0.010 |
Why?
|
Odds Ratio | 1 | 2005 | 9669 | 0.010 |
Why?
|
Patient Readmission | 1 | 2006 | 3288 | 0.010 |
Why?
|
Prevalence | 1 | 2005 | 15869 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 21538 | 0.000 |
Why?
|
Risk Assessment | 1 | 2006 | 24315 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2006 | 39348 | 0.000 |
Why?
|
Hospitalization | 1 | 2004 | 10840 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2005 | 26379 | 0.000 |
Why?
|
Time Factors | 1 | 2006 | 40218 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 41754 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15832 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_